Literature DB >> 19156338

[Molecular aspects of lymph node metastasis].

M Schenck1, H Rübben, E Gulbins.   

Abstract

The risk of local and systemic lymphatic metastasis of a tumor increases with the size of the malignant neoplasia. Lymph vessels are generated in the tumor and seem to follow anatomically defined pathways. However, the precise molecular and biological mechanisms seem to be complex and require definition. At present, molecules belonging to the vascular endothelial growth factors family and podoplanin have been identified as key for the proliferation of the tumor's lacteals. Molecular mechanisms of the tumor origin and the hematogenic and lymphatic dissemination are increasingly better defined by the use of new diagnostic and therapeutic approaches for tumor patients. Simultaneously, we might be able to influence processes such as cell growth, apoptosis, angiogenesis, and lymphogenic dissemination by novel drugs and thereby develop novel approaches for tumor treatment. Chemokine receptors seem to control essential steps of lymphogenic dissemination such as migration, invasion, and proliferation of tumor cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19156338     DOI: 10.1007/s00120-008-1752-z

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  36 in total

Review 1.  LYVE-1, the lymphatic system and tumor lymphangiogenesis.

Authors:  D G Jackson; R Prevo; S Clasper; S Banerji
Journal:  Trends Immunol       Date:  2001-06       Impact factor: 16.687

Review 2.  Lymphatic vasculature development.

Authors:  Guillermo Oliver
Journal:  Nat Rev Immunol       Date:  2004-01       Impact factor: 53.106

Review 3.  Development of the lymphatic vascular system: a mystery unravels.

Authors:  Young-Kwon Hong; Jay W Shin; Michael Detmar
Journal:  Dev Dyn       Date:  2004-11       Impact factor: 3.780

Review 4.  Molecular lymphangiogenesis: new players.

Authors:  Tuomas Tammela; Tatiana V Petrova; Kari Alitalo
Journal:  Trends Cell Biol       Date:  2005-08       Impact factor: 20.808

5.  LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis.

Authors:  C Mouta Carreira; S M Nasser; E di Tomaso; T P Padera; Y Boucher; S I Tomarev; R K Jain
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

Review 6.  Chemokines: agents for the immunotherapy of cancer?

Authors:  Bernhard Homey; Anja Müller; Albert Zlotnik
Journal:  Nat Rev Immunol       Date:  2002-03       Impact factor: 53.106

7.  Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.

Authors:  Kazumi Suzuki; Tatsuo Morita; Akihiko Tokue
Journal:  Int J Urol       Date:  2005-02       Impact factor: 3.369

8.  Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3.

Authors:  M G Achen; S Roufail; T Domagala; B Catimel; E C Nice; D M Geleick; R Murphy; A M Scott; C Caesar; T Makinen; K Alitalo; S A Stacker
Journal:  Eur J Biochem       Date:  2000-05

9.  Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer.

Authors:  Andreas Eisenhardt; Ulrich Frey; Monika Tack; Dieter Rosskopf; Gerd Lümmen; Herbert Rübben; Winfried Siffert
Journal:  Eur Urol       Date:  2005-01       Impact factor: 20.096

Review 10.  Molecular mechanisms of lymphangiogenesis in health and disease.

Authors:  Kari Alitalo; Peter Carmeliet
Journal:  Cancer Cell       Date:  2002-04       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.